These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26935643)

  • 1. Drug Tolerance: A Known Unknown in Translational Neuroscience.
    Bespalov A; Müller R; Relo AL; Hudzik T
    Trends Pharmacol Sci; 2016 May; 37(5):364-378. PubMed ID: 26935643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Address Challenges in Neuroscience Drug Discovery and Development.
    O'Donnell P; Rosen L; Alexander R; Murthy V; Davies CH; Ratti E
    Int J Neuropsychopharmacol; 2019 Jul; 22(7):445-448. PubMed ID: 31139821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connecting Brain Proteomics with Behavioural Neuroscience in Translational Animal Models of Neuropsychiatric Disorders.
    Sarnyai Z; Guest PC
    Adv Exp Med Biol; 2017; 974():97-114. PubMed ID: 28353227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease drug development: translational neuroscience strategies.
    Cummings JL; Banks SJ; Gary RK; Kinney JW; Lombardo JM; Walsh RR; Zhong K
    CNS Spectr; 2013 Jun; 18(3):128-38. PubMed ID: 23472637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational research in spinal cord injury: a survey of opinion from the SCI community.
    Kwon BK; Hillyer J; Tetzlaff W
    J Neurotrauma; 2010 Jan; 27(1):21-33. PubMed ID: 19751098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence.
    Goetghebeur PJ; Swartz JE
    J Psychopharmacol; 2016 Jul; 30(7):586-94. PubMed ID: 27147593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing the Utility of Preclinical Research in Neuropsychiatry Drug Development.
    Kaffman A; White JD; Wei L; Johnson FK; Krystal JH
    Methods Mol Biol; 2019; 2011():3-22. PubMed ID: 31273690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development.
    Caruso A; Frances N; Meille C; Greiter-Wilke A; Hillebrecht A; Lavé T
    J Pharmacol Toxicol Methods; 2014; 70(1):73-85. PubMed ID: 24879942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration.
    Brunner D; Balcı F; Ludvig EA
    Behav Processes; 2012 Feb; 89(2):187-95. PubMed ID: 22155361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of human disease: challenges in enabling translation.
    McGonigle P; Ruggeri B
    Biochem Pharmacol; 2014 Jan; 87(1):162-71. PubMed ID: 23954708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically.
    Brown JW; Rueter LE; Zhang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():53-62. PubMed ID: 24269664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of pharmacokinetic and efficacy data of preclinical studies with statins markedly improves translation of drug efficacy to human trials.
    van de Steeg E; Kleemann R; Jansen HT; van Duyvenvoorde W; Offerman EH; Wortelboer HM; Degroot J
    J Pharmacol Exp Ther; 2013 Dec; 347(3):635-44. PubMed ID: 24049060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational challenges of animal models in Chagas disease drug development: a review.
    Chatelain E; Konar N
    Drug Des Devel Ther; 2015; 9():4807-23. PubMed ID: 26316715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral studies on anxiety and depression in a drug discovery environment: keys to a successful future.
    Bouwknecht JA
    Eur J Pharmacol; 2015 Apr; 753():158-76. PubMed ID: 25460021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular pharmacotherapy: Innovation stuck in translation.
    Rongen GA; Wever KE
    Eur J Pharmacol; 2015 Jul; 759():200-4. PubMed ID: 25814253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General overview: biomarkers in neuroscience research.
    Filiou MD; Turck CW
    Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary pharmacology: screening and interpretation of off-target activities - focus on translation.
    Whitebread S; Dumotier B; Armstrong D; Fekete A; Chen S; Hartmann A; Muller PY; Urban L
    Drug Discov Today; 2016 Aug; 21(8):1232-42. PubMed ID: 27140035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.